To shed further light on the role of physician attire in the medical setting, MPR interviewed Nathan Houchens, MD, Assistant Professor of Internal Medicine at the University of Michigan in Ann Arbor.
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Regulations on telehealth services were rapidly deregulated early into the COVID-19 pandemic, but questions remain about quality of care and patient disparities.
The United States faces “an impending disaster” from the coronavirus pandemic and should spend $75 billion to improve its diagnostic testing system for COVID-19.
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is inadequate for assessing the balance of benefits and harms of primary care interventions for preventing illicit drug use among children, adolescents, and young adults.
In light of the changes inflicted by the COVID-19 pandemic, the researchers wished to explore the effects of the pandemic on stroke management during the first month of Italy’s lockdown.
Researchers sought to identify disparities in risk to prevent, identify, and treat COVID-19-related severe illness and limit diverging outcomes for vulnerable subgroups.
The International Myasthenia Gravis/COVID-19 Working Group has published a short guidance statement on the management of MG and Lambert-Eaton myasthenic syndrome during this novel pandemic.
In patients with COVID-19, higher sputum cell expression of ACE2 and TMPRSS2 was observed in certain patients while lower expression was found in patients who used inhaled corticosteroids.
Publication of the revised clinical practice guidelines for Clostridioides difficile infection was followed by significant increases in use of oral vancomycin and fidaxomicin, and a significant decrease in use of oral metronidazole.
The North American Society Leadership drafted a consensus report synthesizing recommendations by cardiovascular societies dealing with the safe reinstatement of elective procedures and tests.
